Geron Corp. (GERN)
1.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Geron Cash from Operations (Quarterly) : -15.83M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.83M |
| March 31, 2026 | -62.91M |
| December 31, 2025 | -22.07M |
| September 30, 2025 | -13.58M |
| June 30, 2025 | -27.42M |
| March 31, 2025 | -47.98M |
| December 31, 2024 | -43.94M |
| September 30, 2024 | -58.94M |
| June 30, 2024 | -53.48M |
| March 31, 2024 | -62.25M |
| December 31, 2023 | -40.94M |
| September 30, 2023 | -50.84M |
| June 30, 2023 | -29.60M |
| March 31, 2023 | -46.36M |
| December 31, 2022 | -35.18M |
| September 30, 2022 | -29.58M |
| June 30, 2022 | -28.64M |
| March 31, 2022 | -33.97M |
| December 31, 2021 | -22.17M |
| September 30, 2021 | -22.84M |
| June 30, 2021 | -17.81M |
| March 31, 2021 | -32.73M |
| December 31, 2020 | -12.61M |
| September 30, 2020 | -15.45M |
| June 30, 2020 | -12.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -26.19M |
| December 31, 2019 | -10.37M |
| September 30, 2019 | -11.98M |
| June 30, 2019 | -8.745M |
| March 31, 2019 | -12.74M |
| December 31, 2018 | -3.01M |
| September 30, 2018 | -6.136M |
| June 30, 2018 | -4.495M |
| March 31, 2018 | -7.368M |
| December 31, 2017 | -4.387M |
| September 30, 2017 | -4.424M |
| June 30, 2017 | -4.438M |
| March 31, 2017 | -7.307M |
| December 31, 2016 | -0.602M |
| September 30, 2016 | -6.553M |
| June 30, 2016 | -5.636M |
| March 31, 2016 | -5.578M |
| December 31, 2015 | -5.251M |
| September 30, 2015 | -4.905M |
| June 30, 2015 | -6.335M |
| March 31, 2015 | -7.705M |
| December 31, 2014 | 28.48M |
| September 30, 2014 | -4.472M |
| June 30, 2014 | -5.15M |
| March 31, 2014 | -9.505M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Precigen, Inc. | -17.81M |
| Editas Medicine, Inc. | -29.57M |
| Agenus, Inc. | -31.20M |
| Amgen, Inc. | 4.002B |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 8.295M |
| Cash from Financing (Quarterly) | 1.384M |
| Free Cash Flow | -114.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0239 |
| Free Cash Flow to Equity (Quarterly) | -15.98M |
| Free Cash Flow to Firm (Quarterly) | -8.904M |
| Free Cash Flow Yield | -14.01% |